World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
39110
World Ranking
13428
National Ranking
6830

Alok A. Khorana publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alok A. Khorana sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 524 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Alok A. Khorana D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alok A. Khorana sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Alok A. Khorana is affiliated with the Cleveland Clinic in the United States and has a research focus primarily within the field of Medicine, with a notable emphasis on Oncology. Their scholarly contributions span several subfields including Oncology, Internal Medicine, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, and Surgery.

Their publication record includes significant contributions to topics such as Venous Thromboembolism Diagnosis and Management, Central Venous Catheters and Hemodialysis, Inflammatory Biomarkers in Disease Prognosis, Atrial Fibrillation Management and Outcomes, Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, and Colorectal Cancer Screening and Detection.

Alok A. Khorana has authored and contributed to numerous research papers, among which the following stand out:

  • "American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer" (2021, Blood Advances)
  • "2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19" (2022, The Lancet Oncology)
  • "Cancer-associated venous thromboembolism" (2022, Nature Reviews Disease Primers)
  • "Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update" (2023, Journal of Clinical Oncology)
  • "Venous and Arterial Thromboembolism in Patients With Cancer" (2021, JACC CardioOncology)

Their frequent collaborators include Kanika G. Nair, Smitha Krishnamurthi, Suneel D. Kamath, David Liska, and Keith R. McCrae.

Alok A. Khorana commonly publishes research in venues such as the Journal of Clinical Oncology, Blood, Research and Practice in Thrombosis and Haemostasis, Blood Advances, and Thrombosis Research. The distribution of publications indicates a strong dedication to hematology and oncology research within reputable academic journals.

Best Publications

  • Development and validation of a predictive model for chemotherapy-associated thrombosis

    Alok A. Khorana;Nicole M. Kuderer;Eva Culakova;Gary H. Lyman

  • Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

    Alok A. Khorana;C. W. Francis;E. Culakova;N. M. Kuderer

  • American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer

    Gary H. Lyman;Alok A. Khorana;Anna Falanga;Daniel Clarke-Pearson

  • Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

    Nigel S Key;Alok A Khorana;Nicole M Kuderer;Kari Bohlke

  • Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

    Gary H. Lyman;Gary H. Lyman;Kari Bohlke;Alok A. Khorana;Nicole M. Kuderer

  • Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: Asco guideline for geriatric oncology

    Supriya G. Mohile;William Dale;Mark R. Somerfield;Mara A. Schonberg

  • Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.

    Alok A. Khorana;Charles W. Francis;Eva Culakova;Nicole M. Kuderer

  • Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

    Philip A. Philip;Jacqueline Benedetti;Christopher L. Corless;Ralph Wong

  • Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study

    Alok A. Khorana;Charles W. Francis;Eva Culakova;M.P.H. Gary H. Lyman M.D.

  • International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

    D Farge;P Debourdeau;M Beckers;C Baglin

  • Assessing Risk of Venous Thromboembolism in the Patient With Cancer

    Alok A. Khorana;Gregory C. Connolly

  • Thromboembolism in Hospitalized Neutropenic Cancer Patients

    Alok A. Khorana;Charles W. Francis;Eva Culakova;Richard I. Fisher

  • American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

    Gary H. Lyman;Gary H. Lyman;Marc Carrier;Cihan Ay;Marcello Di Nisio

  • Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States†

    Alok A. Khorana;Mehul Dalal;Jay Lin;Gregory C. Connolly

  • 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

    Dominique Farge;Dominique Farge;Corinne Frere;Jean M Connors;Cihan Ay

  • Blood Transfusions, Thrombosis, and Mortality in Hospitalized Patients With Cancer

    Alok A. Khorana;Charles W. Francis;Neil Blumberg;Eva Culakova

  • Tissue Factor Expression, Angiogenesis, and Thrombosis in Pancreatic Cancer

    Alok A. Khorana;Steven A. Ahrendt;Charlotte K. Ryan;Charles W. Francis

  • Venous thromboembolism and prognosis in cancer.

    Alok A. Khorana

  • Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH.

    Alok A. Khorana;S. Noble;A. Y.Y. Lee;G. Soff

  • Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

    Alok A. Khorana;Pamela B. Mangu;Jordan Berlin;Anitra Engebretson

Frequent Co-Authors

Gary H. Lyman
Gary H. Lyman Fred Hutchinson Cancer Research Center
Charles W. Francis
Charles W. Francis University of Rochester Medical Center
Marc Carrier
Marc Carrier Ottawa Hospital
Anna Falanga
Anna Falanga University of Milano-Bicocca
Ingrid Pabinger
Ingrid Pabinger Medical University of Vienna
Guy Meyer
Guy Meyer Université Paris Cité
Ajay K. Kakkar
Ajay K. Kakkar University College London
Lisa Rybicki
Lisa Rybicki Cleveland Clinic
Giancarlo Agnelli
Giancarlo Agnelli University of Perugia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a future in Medicine doesn’t always mean pursuing a traditional M.D. degree. Many successful healthcare professionals follow alternative pathways to enter the field. With the growing demand for specialized skills, there are a variety of online bachelor's in health information management programs that prepare students for roles managing medical data and records.

If you are interested in healthcare administration, technology, or insurance, taking billing and coding classes online can open doors to jobs in medical organizations and hospitals.

Nursing remains a critical and rewarding career. For those seeking flexibility and affordability, cheap online nursing programs offer rigorous training for aspiring RNs, while the cheapest fnp programs online provide avenues to become a Family Nurse Practitioner.

These online degrees and certifications make healthcare careers more accessible, helping you build a foundation to work directly with patients, support healthcare operations, or advance into more specialized roles.

Best Scientists Citing Alok A. Khorana

Trending Scientists

Recently Published Articles